Random screening of proteins for HLA-A*0201-binding nine-amino acid peptides is not sufficient for identifying CD8 T cell epitopes recognized in the context of HLA-A*0201

Journal of Immunology

Volumn 172, Issue 11, 2004, Pages 6783-6789

  Pelte, Christian ^a   Cherepnev, Georgy ^a   Wang, Yanjun ^a   Schoenemann, Constanze ^a   Volk, Hans Dieter ^a   Kern, Florian ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CD8 ANTIGEN; CYTOMEGALOVIRUS PROTEIN; EPITOPE; GAMMA INTERFERON; HLA A ANTIGEN; HLA A2 ANTIGEN; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ALGORITHM; ALLELE; AMINO ACID SEQUENCE; ARTICLE; BIOINFORMATICS; BLOOD DONOR; BONE MARROW CELL; CAUCASIAN; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; EX VIVO STUDY; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN TARGETING; SCREENING; T LYMPHOCYTE;

EID: 2442705373     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.11.6783     Document Type: Article

References (21)

1. Kern, F., I. P. Surel, C. Brock, B. Freistedt, H. Radtke, A. Scheffold, R. Blasczyk, P. Reinke, J. Schneider-Mergener, A. Radbruch, et al. 1998. T-cell epitope mapping by flow cytometry. Nat. Med. 4:975.
2. Hoffmeister, B., F. Kiecker, L. Tesfa, H. D. Volk, L. J. Picker, and F. Kern. 2003. Mapping T cell epitopes by flow cytometry. Methods 29:270.
3. Kern, F., N. Faulhaber, C. Frömmel, E. Khatamzas, S. Prösch, C. Schönemann, I. Kretzschmar, R. Volkmer-Engert, H.-D. Volk, and P. Reinke. 2000. Analysis of CD8 T cell reactivity to cytomegalovirus using protein-spanning pools of overlapping pentadecapeptides. Eur. J. Immunol. 30:1676.
4. Kramer, A., U. Reineke, L. Dong, B. Hoffmann, U. Hoffmuller, D. Winkler, R. Volkmer-Engert, and J. Schneider-Mergener. 1999. Spot synthesis: observations and optimizations. J. Pept. Res. 54:319.
5. Rammensee, H. G., J. Bachmann, and S. Stefanovic. 1997. MHC Ligands and Binding Motifs. Landes Bioscience, Georgetown.
6. Parker, K. C., M. A. Bednarek, and J. E. Coligan. 1994. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J. Immunol. 152:163.
7. +-T-cell response to human cytomegalovirus: the 72-kilodalton major immediate-early protein revisited. J. Virol. 73:8179.
8. Kern, F., T. Bunde, N. Faulhaber, F. Kiecker, E. Khatamzas, I. M. Rudawski, A. Pruss, J. W. Gratama, R. Volkmer-Engert, R. Ewert, et al. 2002. Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals. J. Infect. Dis. 185:1709.
9. Cerundolo, V., J. Alexander, K. Anderson, C. Lamb, P. Cresswell, A. McMichael, F. Gotch, and A. Townsend. 1990. Presentation of viral antigen controlled by a gene in the major histocompatibility complex. Nature 345:449.
10. Wills, M. R., A. J. Carmichael, K. Mynard, X. Jin, M. P. Weekes, B. Plachter, and J. G. Sissons. 1996. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL. J. Virol. 70:7569.
11. + T-cell responses cannot be predicted by major histocompatibility complex class I haplotype. J. Virol. 74:9144.
12. +-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers. J. Virol. 77:5226.
13. Diamond, D. J., J. York, J. Y. Sun, C. L. Wright, and S. J. Forman. 1997. Development of a candidate HLA A*0201 restricted peptide-based vaccine against human cytomegalovirus infection. Blood 90:1751.
14. Nakagawa, Y., T. Takeshita, J. A. Barzofsky, and H. Takahashi. 2000. Analysis of the mechanism for extracellular processing in the presentation of human immunodeficiency virus-1 envelope protein-derived peptide to epitope-specific cytotoxic T lymphocytes. Immunology 101:76.
15. Sherman, L. A., T. A. Burke, and J. A. Biggs. 1992. Extracellular processing of peptide antigens that bind class I major histocompatibility molecules. J. Exp. Med. 175:1221.
16. Sun, Y., E. Iglesias, A. Samri, G. Kamkamidze, T. Decoville, G. Carcelain, and B. Autran. 2003. A systematic comparison of methods to measure HIV-1 specific CD8 T cells. J. Immunol. Methods 272:23.
17. Reddehase, M. J. 2002. Antigens and immunoevasins: opponents in cytomegalovirus immune surveillance. Nat. Rev. Immunol. 2:831.
18. Gilbert, M. J., S. R. Riddell, C. R. Li, and P. D. Greenberg. 1993. Selective interference with class I major histocompatibility complex presentation of the major immediate-early protein following infection with human cytomegalovirus. J. Virol. 67:3461.
19. Del Val, M., H. Volkmer, J. B. Rothbard, S. Jonjic, M. Messerle, J. Schickedanz, M. J. Reddehase, and U. H. Koszinowski. 1988. Molecular basis for cytolytic T-lymphocyte recognition of the murine cytomegalovirus immediate-early protein pp89. J. Virol. 62:3965.
20. Reddehase, M. J., J. B. Rothbard, and U. H. Koszinowski. 1989. A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes. Nature 337:651.
21. Chee, M. S., A. T. Bankier, S. Beck, R. Bohni, C. M. Brown, R. Cerny, T. Horsnell, C. A. Hutchison, 3rd, T. Kouzarides, J. A. Martignetti, et al. 1990. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr. Top. Microbiol. Immunol. 154:125.